Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT06150300

Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

This is a randomized control trial evaluating the effect of a novel mobile application-delivered pulmonary rehabilitation program in adult severe asthma patients. The intervention will include eight weeks of exercise videos that progress in difficulty, as well as asthma-specific educational content. The primary outcome measure is change in functional exercise capacity as measured by six-minute walk distance. Secondary outcome measures will include evaluation of overall feasibility, and change in CPET parameters such as VO2max. Change in asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) and PRAISE self-efficacy score will also be evaluated.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years and older with a diagnosis of asthma by a respirologist. They must have severe disease defined by GINA severity classification. Participants must have access to a smartphone or internet browser to allow access to study content.

Exclusion criteria

  • Exclusion criteria include comorbid cardiopulmonary or musculoskeletal conditions that may impact exercise tolerance in accordance with the American Thoracic Society CPET guidelines

Treatment and study plan

Pulmonary rehab program

Behavioral

Exercise videos, breathing exercises, and educational messages delivered virtually

Placebo

Behavioral

Breathing exercises and educational messages

Primary outcomes

  1. CPET

    Time frame: After 8 weeks of intervention

    VO2max

Study contacts

Contact information is provided by the study sponsor or research team.

Brianne Philipenko, MD

CONTACT

[email protected]

306-956-3444

Sponsors and collaborators

Lead sponsor

University of Saskatchewan

Other

Registry information

Official study title

STAPLE (Severe asThmA PuLmonary rEhab): Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

Acronym: STAPLE

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Nov 29, 2023
Registry last updated
Nov 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.